Although not mutually exclusive, a second possibility that may account for the BCAR3-dependent Rac1 activity observed in invasive breast cancer cells is that BCAR3 may actively suppress RhoA signaling, leading indirectly to Rac1 activation (see Fig. 8). Here, RHOA is linked to breast carcinoma.